Ablation Devices Market Report 2024

The ablation devices market size has grown strongly in recent years. It will grow from $7.78 billion in 2023 to $8.49 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historical period can be attributed to an increasing burden of chronic diseases, a growing elderly population, government initiatives and funding support, advancements in clinical evidence and research, and heightened awareness among physicians.

The ablation devices market size is expected to see strong growth in the next few years. It will grow to $12.13 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the expansion of healthcare infrastructure, improved integration of ablation devices with imaging technologies, rising disposable incomes, accelerated regulatory approvals, and increasing patient awareness. Major trends expected in this period include the growing use of robotics in procedures, expansion into non-oncology applications, advancements in real-time imaging modalities, the rise of telemedicine and remote monitoring, and the increasing adoption of personalized and patient-specific ablation treatment plans.

The ablation device market is poised for growth driven by the increasing prevalence of chronic diseases. Lifestyle changes, aging populations, and longer lifespans contribute to the rising incidence of chronic conditions. Ablation devices play a critical role in treating chronic diseases by selectively destroying abnormal tissue, offering minimally invasive treatment options for conditions such as cardiac arrhythmias and certain cancers. For example, a report from the American College of Cardiology projected significant increases in cardiovascular risk factors and disease rates in the United States from 2025 to 2060. This includes diabetes, dyslipidemia, hypertension, obesity, stroke, heart failure, ischemic heart disease, and heart attack. Thus, the growing prevalence of chronic diseases is a key driver propelling the ablation device market.

Leading companies in the ablation devices market are actively developing innovative solutions, such as the cryoballoon ablation system, for treating conditions such as Barrett’s esophagus. The cryoballoon ablation system is a balloon-based catheter used to freeze and ablate tissue, particularly effective in cardiac arrhythmia treatment. For instance, in October 2022, Pentax of America Inc., a Japanese medical device company, launched the C2 CryoBalloon Ablation System in Canada to treat Barrett's esophagus. This system has demonstrated superior effectiveness compared to traditional Radio Frequency Ablation (RFA), reducing patient discomfort and the need for pain medication.

In August 2022, Medtronic plc, an Ireland-based medical device company, acquired Affera Inc. to expand its cardiac ablation portfolio. This acquisition enhances Medtronic's capabilities in managing atrial and ventricular arrhythmias, marking a significant growth opportunity in the ablation device market. Affera Inc., based in the US, specializes in providing advanced ablation devices.

Major companies operating in the ablation devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Alcon Inc., Olympus Corporation, Smith And Nephew PLC, Cynosure Inc., Hologic Inc., Bausch And Lomb Incorporated, Varian Medical Systems, CONMED Corporation, Avanos Medical Inc., Japan Lifeline Co., AtriCure Inc., AngioDynamics Inc., Syneron Medical Ltd., Dornier MedTech GmbH, EDAP TMS, CathRx Ltd.

North America was the largest region in the ablation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ablation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ablation devices are medical instruments used to eliminate abnormal tissue growths or dysfunctional cells, such as tumors or cardiac arrhythmias, employing various energy sources such as heat, cold, or radiofrequency. These devices play a crucial role in minimally invasive procedures aimed at treating conditions ranging from cancer to heart rhythm disorders.

The primary types of ablation devices include laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators, and cryoablators. Laser ablators utilize laser energy for precise material removal or modification, commonly applied in industrial settings. The technology encompasses various methods such as radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others, often incorporating automated and robotic functionalities. These devices are utilized by diverse end-users including hospitals, clinics, ambulatory surgical centers, and others.

The ablation device market research report is one of a series of new reports that provides ablation device market statistics, including ablation device industry global market size, regional shares, competitors with a ablation device market share, detailed ablation device market segments, market trends and opportunities, and any further data you may need to thrive in the ablation device industry. This ablation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ablation devices market consists of sales of medical devices such as irreversible electroporation (IRE) ablators, photodynamic therapy (PDT) ablators, high-intensity focused ultrasound (HIFU) ablators, chemical ablators, and mechanical ablators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.